Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Physicians Choose OpenEvidence Over Every Other AI Chatbot Combined in Independent Stanford-Harvard Study of Clinical AI

      OpenEvidence Logo

      News provided by

      OpenEvidence

      Jul 20, 2026, 09:32 ET

      Share this article

      Share this article


      When free to consult any resource, physicians turned to OpenEvidence more than ChatGPT, Claude, Gemini, and all other external AI chatbots combined — the most-used AI resource physicians chose on their own in the NOHARM study

      MIAMI, July 20, 2026 /PRNewswire/ -- OpenEvidence, America's most widely used medical knowledge platform, today announced a central finding of the independent Stanford-Harvard NOHARM study: when practicing physicians were free to consult any clinical decision support AI tool, they chose OpenEvidence more than every other external AI chatbot combined.

      The study, NOHARM (Numerous Options Harm Assessment for Risk in Medicine), conducted by ARISE, a clinical AI research network led by physicians from Stanford and Harvard Medical Schools, evaluated 45 large language models and 4 clinical AI systems, with 12,747 expert annotations across 4,249 potential clinical actions.

      Although the NOHARM benchmarking studies are not peer reviewed and should be taken with a grain of salt, the study captured something no benchmark can: the revealed preferences of practicing physicians. In a randomized study of 101 board-certified U.S. physicians, one arm gave physicians complete freedom — any tool of their choosing. Working through real clinical cases, physicians reached for OpenEvidence in 22.3% of their responses: more than ChatGPT, Claude, Gemini, and every other external AI combined (19.8%).

      This real world data is a leading indicator of revealed preference and physician trust. Revealed preference is the most demanding metric of a clinical tool. Physicians are incredibly savvy users of medical technology. They train for over a decade to apply evidence to real world cases. A physician knows within a handful of queries whether an AI meets the standard of medicine. Physicians do not return to tools that fail them, and their daily use cannot be bought, bundled, or engineered into a workflow. It can only be earned, one accurate answer at a time. When the choice was entirely theirs, they made it: OpenEvidence.

      The same study data records the other end of that spectrum. The number of physicians who reached for Doximity Ask — in any case, in any response — was not released.

      Why Physicians Choose OpenEvidence

      OpenEvidence has never paid, incentivized, or compensated a single physician to use it. Every one of the hundreds of thousands of verified clinicians who consult OpenEvidence daily arrived the same way the physicians in the NOHARM study did: on their own, because they trust what they find there. Adoption of OpenEvidence is a choice, made independently, hundreds of thousands of times a day, at the point of care.

      That trust flows from a simple principle: every OpenEvidence answer is sourced, cited, and grounded in the peer-reviewed medical literature.

      EvidenceGrade™: Grading the Evidence, Not the Answers

      Last week, OpenEvidence extended that principle with the launch of EvidenceGrade™, which grades and visualizes — in real time, on every answer — the quality of the published evidence cited in and used to inform that answer. Built on the GRADE framework, the methodology behind Cochrane, the World Health Organization, and most major clinical guidelines, EvidenceGrade gives every clinician an at-a-glance view of how much weight the underlying evidence can bear.

      OpenEvidence believes the trustworthiness of a medical answer is determined by the strength of the evidence beneath it — not by the number of reviewers retained to approve it after the fact. Answer-checking happens behind closed doors and asks physicians to take the result on faith. Evidence grading happens in the open, on every answer, where every clinician can see it and judge it for themselves. That is the standard evidence-based medicine has demanded for thirty years, and it is the standard clinical AI must meet.

      "The most important benchmark in clinical AI isn't administered by researchers — it's administered by physicians, hundreds of thousands of times a day, every time they decide what to consult before making a decision that affects a patient," said Daniel Nadler, founder and CEO of OpenEvidence. "Physicians choose OpenEvidence for the same reason they cite the literature: because trust in medicine is earned through evidence, in the open, one answer at a time."

      To learn more, visit www.openevidence.com.

      About OpenEvidence

      OpenEvidence is the most widely-used clinical decision support platform in the United States, and the most widely used medical search engine among U.S. clinicians. OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature. Independent studies show that more American doctors use OpenEvidence than use all other AI platforms combined. Founded with the mission to organize and expand global medical knowledge, OpenEvidence is actively used daily, on average, by the majority of physicians in the United States.

      SOURCE OpenEvidence

      Note to editors

      Notes to Editors: Full study: Wu et al. 2026, arXiv:2512.01241 (v4)(preprint); Resource-use figures are from Extended Data Fig. 4a, "Resources physicians used in the Any Resource arm" (n = 202 responses; physicians could name multiple resources per response): Provided AI (GPT-5.4, supplied within the study workflow) 44.6%; Google Search 27.2%; UpToDate 24.3%; OpenEvidence 22.3%; External AI — which the study defines as "ChatGPT, Claude, Gemini, and similar tools" — 19.8%; None 12.9%; PubMed/journals 8.4%. Doximity Ask was not reported by any physician in any response; In the study's exploratory manual testing of clinical AI products (Extended Data Fig. 3g), one system was tested on May 15, 2026 and scored 59.6 — below OpenEvidence (60.8) — then "indicated they were in the middle of system updates at the time of testing and requested repeat" testing on May 21, 2026. Both results appear in the published study; the retest result is the one featured in subsequent coverage. The study notes manual testing dates varied across products (April–May 2026) and "may impact scores."

      Modal title

      Also from this source

      OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer

      OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer

      OpenEvidence, America's most widely used medical knowledge platform, today announced EvidenceGrade, a new feature that grades and visualizes, in real ...

      OpenEvidence launches Coding Intelligence™ to help physicians capture every dollar they've earned

      OpenEvidence launches Coding Intelligence™ to help physicians capture every dollar they've earned

      OpenEvidence, the most widely used medical AI and clinical decision-support platform among U.S. physicians, today announced the launch of Coding...

      More Releases From This Source

      Explore

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Medical Equipment

      Medical Equipment

      Computer Software

      Computer Software

      Artificial Intelligence

      Artificial Intelligence

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.